罗米普洛斯蒂姆
医学
化疗
随机化
临床终点
血小板
外科
内科学
随机对照试验
血小板生成素
干细胞
遗传学
生物
造血
作者
Gerald A. Soff,Yimei Miao,Gemma Bendheim,Jeanette Batista,Jodi V. Mones,Rekha Parameswaran,Cy R. Wilkins,Sean M. Devlin,Ghassan K. Abou‐Alfa,Andrea Cercek,Nancy E. Kemeny,Debra Sarasohn,Simon Mantha
摘要
This prospective trial evaluated treatment of CIT with romiplostim. Romiplostim is effective in correcting CIT, and maintenance allows for resumption of chemotherapy without recurrence of CIT in most patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI